A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2022; you can also visit the original URL.
The file type is application/pdf
.
How Nanotherapy Fails SARS-CoV-2: The BI(G)MED Experience
2021
Clinical Immunology & Research
While the Sars-CoV-2 epidemics seems to rebound more and more despite the massive vaccination surveys that prove not only moderately efficacy but more deleterious effects than expected, the need for an effective treatment against the coronavirus is imperatively needed. In this article we present such a treatment, based on empirical clinical observations. The goal of this treatment is to give hope to as many patients as possible for the existence of an effective and safe treatment without any side effect.
doi:10.33425/2639-8494.1041
fatcat:qog5i26kmnh5xcj67lluhga4nm